Dare Bioscience, Inc.
DARE- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001401914
No open-market purchases or sales by Dare Bioscience, Inc. insiders were filed in the last 90 days; 27 institutions reported holding it in 13F filings for Q2 2026, worth $2.75M in total; no superinvestor holds it.
Q3 2022 vs. Q2 2022
How the institutions holding Dare Bioscience, Inc. changed between Q2 2022 and Q3 2022.
All holders in Q3 2022All holders in Q2 2022
| Measure | Q2 2022 | Q3 2022 | Change |
|---|---|---|---|
| Holders | 36 | 31 | −5 |
| Shares | 7.42M | 7.80M | +377.7K (+5.1%) |
| Value | $9.12M | $7.56M | −$1.56M (−17.1%) |
New holders (2)
Institutions that held Dare Bioscience, Inc. at the end of Q3 2022 but not at the end of Q2 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| HRT Financial LP | 13,766 | $13.0K | 0.00% |
| Royal Bank of Canada | 16 | $0 | 0.00% |
Sold out (7)
Institutions that held Dare Bioscience, Inc. at the end of Q2 2022 and filed for Q3 2022 without it.
| Institution | Shares, Q2 2022 | Value, Q2 2022 |
|---|---|---|
| Founders Financial Alliance, LLC | 102,500 | $126.0K |
| Gsa Capital Partners LLP | 32,350 | $40.0K |
| XTX Topco Ltd | 18,846 | $23.0K |
| Cubist Systematic Strategies, LLC | 16,839 | $21.0K |
| Victory Capital Management Inc | 11,425 | $14.0K |
| Artemis Wealth Advisors, LLC | 881 | $1.00K |
| High Net Worth Advisory Group LLC | 1,000 | $1.00K |